Missing Avatar

Ronald Jäger

Postdoctoral Fellow - Dept. of Physiology

Position - Company  
Postdoctoral Fellow - Dept. of Physiology Northwestern University The Feinberg School of Medicine 2011 - Present
Degree - University  
Dr. rer. nat., Pharmacology - Ruhr-Universität Bochum 2005 - 2010
Diplom Biochemiker, Biochemistry - Ruhr-Universität Bochum 2000 - 2005
Publication Info
Stress management at the ER: Regulators of ER stress-induced apoptosis. Gorman AM, Healy SJ, Jäger R, Samali A Pharmacol Ther. 134(3):306-16. doi: 10.1016/j.pharmthera.2012.02.003. June 2012. View on PubMed.
The unfolded protein response at the crossroads of cellular life and death during endoplasmic reticulum stress. Jäger R, Bertrand MJ, Gorman AM, Vandenabeele P, Samali A Biol Cell. 104(5):259-70. doi: 10.1111/boc.201100055. May 2012. View on PubMed.
Disorder mapping in VCSELs using frequency-selective feedback. Ackemann T, Radwell N, Noblet Y, Jäger R Opt Lett. 37(6):1079-81. March 15, 2012. View on PubMed.
Activation of PDE10 and PDE11. Jager R, Russwurm C, Schwede F, Genieser HG, Koesling D, Russwurm M J Biol Chem. :. doi: 10.1074/jbc.M111.263806. November 21, 2011. View on PubMed.
Lactogenic differentiation of HC11 cells is not accompanied by downregulation of AP-2 transcription factor genes. Jäger R, Pappas L, Schorle H BMC Res Notes. 4:345. doi: 10.1186/1756-0500-4-345. September 9, 2011. View on PubMed.
Immune tolerance induction with a factor VIII concentrate containing von Willebrand factor (Haemoctin SDH®) in 14 patients with severe haemophilia A. Bidlingmaier C, Kurnik K, Escuriola-Ettingshausen C, Jager R, Klamroth R, Male C, Marosi A, Nemes L, von Stackelberg A, Kreuz W Haemophilia. 17(5):e837-40. doi: 10.1111/j.1365-2516.2011.02577.x. September 2011. View on PubMed.
Genome integrity of myeloproliferative neoplasms in chronic phase and during disease progression. Klampfl T, Harutyunyan A, Berg T, Gisslinger B, Schalling M, Bagienski K, Olcaydu D and 12 others Blood. 118(1):167-76. doi: 10.1182/blood-2011-01-331678. July 7, 2011. View on PubMed.
Analysis of the efficacy, safety, and regulatory status of novel forms of creatine. Jäger R, Purpura M, Shao A, Inoue T, Kreider RB Amino Acids. 40(5):1369-83. doi: 10.1007/s00726-011-0874-6. May 2011. View on PubMed.
Common large partial VWF gene deletion does not cause alloantibody formation in the Hungarian type 3 von Willebrand disease population. Mohl A, Boda Z, Jager R, Losonczy H, Marosi A, Masszi T, Nagy E and 11 others J Thromb Haemost. 9(5):945-52. doi: 10.1111/j.1538-7836.2011.04250.x. May 2011. View on PubMed.
Preoperative oxaliplatin, capecitabine, and external beam radiotherapy in patients with newly diagnosed, primary operable, cT₃NxM0, low rectal cancer: a phase II study. Ofner D, Devries AF, Schaberl-Moser R, Greil R, Rabl H, Tschmelitsch J, Zitt M and 9 others Strahlenther Onkol. 187(2):100-7. doi: 10.1007/s00066-010-2182-6. February 2011. View on PubMed.
Activation of PDE2 and PDE5 by specific GAF ligands: delayed activation of PDE5. Jäger R, Schwede F, Genieser HG, Koesling D, Russwurm M Br J Pharmacol. 161(7):1645-60. doi: 10.1111/j.1476-5381.2010.00977.x. December 2010. View on PubMed.
Design of fluorescence resonance energy transfer (FRET)-based cGMP indicators: a systematic approach. Russwurm M, Mullershausen F, Friebe A, Jäger R, Russwurm C, Koesling D Biochem J. 407(1):69-77. doi: 10.1042/BJ20070348. October 1, 2007. View on PubMed.
Dimerization of nitric oxide-sensitive guanylyl cyclase requires the alpha 1 N terminus. Wagner C, Russwurm M, Jäger R, Friebe A, Koesling D J Biol Chem. 280(18):17687-93. doi: 10.1074/jbc.M412099200. May 6, 2005. View on PubMed.
  • Ronald Jäger hasn't received any ratings yet...